Integrative Metabolomics and Transcriptomics Analysis Reveals Novel Therapeutic Vulnerabilities in Lung Cancer

Scientists identified unique metabolite-related gene signatures specific for lung adenocarcinoma and lung squamous cell carcinoma and key pathways aberrantly regulated at both transcriptional and metabolic levels.